Literature DB >> 12725316

Primary endocrinomas (carcinoids and variant neoplasms) of the gallbladder. A statistical evaluation of 138 reported cases.

J Soga1.   

Abstract

This study was carried out to obtain extensive information on carcinoids (the carcinoid group) and related variant endocrinomas (the variant group) of the gallbladder, and to statistically analyze their characteristics from various clinicopathologic aspects. A total of 138 cases were collected from the international sources, 101 belonging to the carcinoid group and 37 to the variant group. The first group consisted of 81 cases of typical and 20 atypical carcinoids. Comparative evaluation was attempted mainly between the carcinoid and variant groups, and occasionally between the typical and atypical carcinoid series when statistical significance was suspected. The carcinoid group showed a statistically significant difference from the variant group by exhibiting a younger average age (61.7 years vs 69.7 years: P<0.01), a higher incidence of associated cholelithiasis (87.3% vs 56.0%: P<0.01), a higher incidence of small tumors 50 mm or less (85.2% vs 52.9%: P<0.01), a smaller average tumor-size (29.6 mm vs 58.7 mm: P<0.01), a lower rate of metastases (40.7% vs 70.6%: P<0.05), a higher immunoreactivity rate of chromogranin (100.0% vs 66.7%: P<0.01), a lower immunoreactivity rate of gastrin (23.8% vs 70.6%: P<0.01), and a higher five-year survival rate (60.4% vs 21.3%: P<0.0005). Significant differences in various clinicopathological aspects confirmed between the carcinoid group and the variant group suggested that endocrine carcinomas of these two groups perform a different clinical pattern, represented most clearly by postoperative outcomes. These groupings are decided on the basis of histologic patterns, namely, well to poorly differentiated endocrine carcinomas (typical to atypical carcinoids) and undifferentiated or anaplastic variants of other endocrine carcinomas. The basic criteria for such classification of these endocrine carcinomas based on international agreements are required.

Entities:  

Mesh:

Year:  2003        PMID: 12725316

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  18 in total

1.  Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer.

Authors:  Jing-Ting Jiang; Chang-Ping Wu; Hai-Feng Deng; Ming-Yang Lu; Jun Wu; Hong-Yu Zhang; Wen-Hui Sun; Mei Ji
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

2.  Primary carcinoid tumor of the gallbladder: a case report and brief review of the literature.

Authors:  Yi-Ping Zou; Wei-Min Li; Hao-Run Liu; Ning Li
Journal:  World J Surg Oncol       Date:  2010-02-23       Impact factor: 2.754

3.  Neuroendocrine liver metastasis in gastric mixed adenoneuroendocrine carcinoma with trilineage cell differentiation: a case report.

Authors:  Wenjin Zhang; Weihua Xiao; Haifen Ma; Mingfei Sun; Hongtan Chen; Shusen Zheng
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  Unusual and Aggressive Cause of Gall Bladder Mass-Neuroendocrine Tumor.

Authors:  Naveen Padmanabhan; Suhail Ahmed; Ann Kurian; P Ravishankar
Journal:  J Gastrointest Cancer       Date:  2020-03

5.  Conversion surgery after extensive chemotherapy for stage IV mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: clinical implications from the patterns of response and recurrence.

Authors:  Keiko Kamei; Junichi Shindoh; Yoshitaka Kiya; Ippei Matsumoto; Masaji Hashimoto; Yoshifumi Takeyama
Journal:  Clin J Gastroenterol       Date:  2019-10-15

6.  Neuroendocrine tumor of gallbladder with liver and retroperitoneal metastases and a good response to the chemotherapeutical treatment.

Authors:  Liliana Chiorean; Adrian Bartos; Doris Pelau; Dana Iancu; Tudor Ciuleanu; Rares Buiga; Irinel Oancea; Angelica Mangrau; Cornel Iancu; Radu Badea
Journal:  J Med Ultrason (2001)       Date:  2014-10-25       Impact factor: 1.314

Review 7.  Malignant neuroendocrine tumour of the gallbladder with elevated carcinoembryonic antigen: case report and literature review.

Authors:  Muhammad Furrukh; Asim Qureshi; Anna Saparamadu; Shiyam Kumar
Journal:  BMJ Case Rep       Date:  2013-05-08

8.  Neuroendocrine tumor of the gallbladder.

Authors:  Ahmed Monier; Nehal Saloum; Wojciech Szmigielski; Amal Alrashid; Sarbar M E Napaki
Journal:  Pol J Radiol       Date:  2015-01-05

9.  Neuroendocrine neoplasms of liver - A 5-year retrospective clinico-pathological study applying World Health Organization 2010 classification.

Authors:  Deepak Kalyansingh Burad; Thomas Alex Kodiatte; Sayd Mohamed Rajeeb; Ashish Goel; Chundamannil Eapen Eapen; Banumathi Ramakrishna
Journal:  World J Gastroenterol       Date:  2016-10-28       Impact factor: 5.742

10.  Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy.

Authors:  Wu Song; Wenfang Chen; Sheng Zhang; Jianjun Peng; Yulong He
Journal:  Diagn Pathol       Date:  2012-11-27       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.